US Stocks
NERV

Minerva Neurosciences, Inc

$7.89
+0.03 (+0.38%)

Volume:

204.095K ($1.61M)

Market Capitalization:

$341.44M

Minerva Neurosciences, Price Chart

Minerva Neurosciences, Price Chart 4:11 AM 5:31 AM 6:51 AM 8:11 AM 9:31 AM 10:51 AM 12:11 PM8.258.168.088.007.917.837.74

Minerva Neurosciences, Volume Chart

Minerva Neurosciences, Volume Chart 4:11 AM5:31 AM6:51 AM8:11 AM9:31 AM10:51 AM12:11 PM 29.82K25.56K21.30K17.04K12.78K8.52K4.26K

Minerva Neurosciences, Market Segments

Regular Trading Hours

+0.15(+1.94%)
Open$7.74
Close$7.89
Low$7.74
Low Change0.00 (0.00%)
High$8.25
High Change+0.51 (+6.59%)
Range$0.51
Volume204.095K
Dollar Volume$1.61M

Premarket

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

+0.11(+1.42%)
Open$7.75
Close$7.86
Low$7.67
Low Change-0.08 (-1.03%)
High$8.80
High Change+1.05 (+13.55%)
Range$1.13
Volume352.838K
Dollar Volume$2.77M

Premarket Yesterday

+0.06(+0.77%)
Open$7.83
Close$7.89
Low$7.83
Low Change0.00 (0.00%)
High$7.89
High Change+0.06 (+0.77%)
Range$0.06
Volume1.244K
Dollar Volume$9.82K

Minerva Neurosciences, Moving Averages

5 Day Moving Average (SMA5)$7.71
10 Day Moving Average (SMA10)$7.23
20 Day Moving Average (SMA20)$6.84
50 Day Moving Average (SMA50)$5.53
100 Day Moving Average (SMA100)$4.81
200 Day Moving Average (SMA200)$3.42

Minerva Neurosciences, Statistics

Average Volume (30 Days)169.53K
P/E Ratio (Current)-1.15
EPS (Current)-$6.78
Dividend Yield0.00%
Free Cash Flow
Cash Ratio35.93
Current Ratio36.24
Quick Ratio36.24
Debt to Equity0.00
Enterprise Value$256.54M
EV to EBITDA-16.99
EV to Sales
Price to Book-2.41
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-3.00%
Return on Equity2.08%

Minerva Neurosciences, Stock Splits

There has been 1 stock split for Minerva Neurosciences, (NERV). The reverse stock split occured on June 21, 2022 and reduced the outstanding shares at a ratio of 8:1.

DateTypeRatio
Jun 21, 2022Reverse8:1

Minerva Neurosciences, Dividends

There have been no dividends for Minerva Neurosciences, (NERV).